Michelle Dawson posts

Post published on Twitter/X on 13 Apr 2022 04:46

Back to posts Previous post Next post
Twitter/X Clinical trial clinicaltrials.gov Extract quoted in the post External link integrated into the post Autism terms
Open original post

Information about the link integrated into the post

Clinical trial

Guangzhou Women and Children's Medical Center (2018). Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder. ClinicalTrials.gov. Guangzhou Women and Children's Medical Center.

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Guangzhou Women and Children's Medical Center (2018). Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder. ClinicalTrials.gov. Guangzhou Women and Children's Medical Center.

Publication date
20 Jan 2018
Identifier
NCT03434366
Authors
Guangzhou Women and Children's Medical Center
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Guangzhou Women and Children's Medical Center
Metadata source
clinicaltrials.gov

Abstract

Autism spectrum disorder (ASD) is a life-long neurodevelopmental disorder characterized by qualitative abnormalities in reciprocal social interactions and patterns of communication, and by a restricted, stereotyped, repetitive repertoire of interests and activities. The use of medications in adolescents and young adults with ASD is extremely common. However, few data address the effectiveness and harms of medications specifically in this population. The purpose of the study is to determine the efficacy and safety of intranasal ketamine with dexmedetomidine in children with ASD.

Open source Link to cited source